glp 1 agonist vs sglt2 inhibitor GLP-1 receptor agonists and inhibitors: a couple at last? Complementary Yet Distinct Roles of
Description
John M, Kalra S, Nair T
Clinical trials report an average of 1215% body weight reduction in patients using GLP-1 drugs like Wegovy and Mounjaro
Kang DH et al
SAR441255 also reduced body weight (~12%) in DIO monkeys after 7 weeks, confirming its efficacy in mammalian species (66, 69)
These interventions are relatively new, and trials are ongoing for new indicators of obesity-related diseases
